2021
DOI: 10.1002/slct.202100854
|View full text |Cite
|
Sign up to set email alerts
|

Identification of SARS‐CoV‐2 Main Protease Inhibitors Using Structure Based Virtual Screening and Molecular Dynamics Simulation of DrugBank Database

Abstract: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) is highly pathogenic to humans and has created an unprecedented global health care threat. Globally, intense efforts are going on to discover a vaccine or new drug molecules to control the COVID‐19. However, till today, there is no effective therapeutics or treatment available for COVID‐19. In this study, we aim to find out potential small molecule inhibitors for SARS‐CoV‐2 main protease (M pro ) from the known DrugBank databas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(8 citation statements)
references
References 48 publications
(90 reference statements)
0
8
0
Order By: Relevance
“…The three-dimensional structure of SARS-CoV-2's main protease has been determined, offering valuable insights for drug design. This information helps researchers identify compounds specifically targeting and inhibiting the main protease, disrupting the viral life cycle [ 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…The three-dimensional structure of SARS-CoV-2's main protease has been determined, offering valuable insights for drug design. This information helps researchers identify compounds specifically targeting and inhibiting the main protease, disrupting the viral life cycle [ 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…Studying protein–drug interactions is essential to comprehending the structural requirements for ligand affinity. 45,46 The DrugBank 47 dataset is also used to construct protein-drug interactions. We used this (version 1.0) 48 database to find potential medications that significantly interact with genes.…”
Section: Methodsmentioning
confidence: 99%
“…Cobicistat, flavin adenine dinucleotide, and simeprevir were suggested through drug ranking according to binding energy by MM/PB­(GB)­SA calculations. Other assessments based on docking and MM/PB­(GB)­SA calculations focused on specific drugs or compounds such as ravidasvir, lopinavir, ritonavir, saquinavir, teicoplanin, GC-376, calpain XII, calpain II, anti-HIV drugs, doxorubicin, chloroquine, quinoline, hydroxychloroquine, noscapine, echinocandins, coumarins, and their derivatives. …”
Section: Methods and Approachesmentioning
confidence: 99%